Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotic Preparations for Decolonization of Carbapenem-Resistant Enterobacterales
NCT07707869Active, not recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Mar 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Trial of Lactobacillus rhamnosus GG in Enterobacteriaceae colonization (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoints: Clearance Rate of Intestinal CRO at 1 month and Safety assessment at 1 month. Started Mar 2026; status: active, not recruiting.
02
Drugs
Lactobacillus rhamnosus GG
03
Conditions
Enterobacteriaceae colonization
Beyond the preview
Go deeper on NCT07707869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07707869.